https://healthcommcapacity.org/wp-content/uploads/2014/05/Spotlight-on-Oxytocin-and-Misoprostol-for-Postpartum-Hemorrhage-232x3001.png 300 232 Marla Shaivitz | Digital Communications Manager, HC3 https://healthcommcapacity.org/wp-content/uploads/2014/04/HC3logo285px.jpg Marla Shaivitz | Digital Communications Manager, HC32014-05-13 15:54:102017-01-22 21:33:15Spotlight on Oxytocin and Misoprostol for Postpartum Hemorrhage
Spotlight on Oxytocin and Misoprostol for Postpartum Hemorrhage
This fact sheet is part of a series on Demand Generation for 13 Life-Saving Commodities: A Synthesis of the Evidence.
Oxytocin and misoprostol remain underutilized in the prevention of postpartum hemorrhage (PPH), and as such, have been identified by the UN Commission on Life-Saving Commodities for Women’s and Children’s Health as two of 13 commodities that if more widely accessed and properly used, could save the lives of more than six million women and children worldwide.
[Download] Spotlight on Oxytocin and Misoprostol for Postpartum Hemorrhage
[Download] French version